ENTITY
Cargo Therapeutics

Cargo Therapeutics (CRGX US)

1
Analysis
Health CareUnited States
Cargo Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing chimeric antigen receptor (CAR) T-cell therapies for the treatment of cancer patients. Cargo Therapeutics serves customers in the United States.
more
Exchange Announcement13 Aug 2024 04:53
Exchange Announcement13 Aug 2024 04:06
Exchange Announcement09 Jul 2024 04:18
Exchange Announcement28 Jun 2024 04:28
x